Minimizing Disability from Graft-Versus-Host Disease

被引:0
|
作者
Andrews C.C. [1 ]
机构
[1] Department of Physical Medicine and Rehabilitation, University of Michigan, 325 E. Eisenhower Pkwy, Ann Arbor, 48108, MI
关键词
Avascular necrosis; Cancer rehabilitation; Chronic graft-versus-host disease; Fascial GVHD; Steroid myopathy;
D O I
10.1007/s40141-018-0189-6
中图分类号
学科分类号
摘要
Purpose of Review: Graft-versus-host disease (GVHD) is a complication of hematopoietic stem cell transplantation which can result in significant disability. Any organ system may be affected, and as a result, a wide variety of functional impairments may occur. Rehabiliation services can improve patient outcomes and quality of life, but an understanding of the underlying disease process is necessary. Recent Findings: There have been few studies published recently regarding the management of functional impairments in GVHD patients. The National Institutes of Health Consensus Development Project on Criteria in Chronic Graft-versus-Host Disease is an ongoing project begun in 2005 and most recently updated in 2014; however, these data have not yet been used to assess the management of disability in this population. Summary: The treatment of functional impairments from GVHD remains largely annectdotal and based around experiences from similar diseases; however, rehabilitation interventions should still be considered for patients with significant disease burden. © 2018, Springer Science+Business Media, LLC, part of Springer Nature.
引用
收藏
页码:131 / 135
页数:4
相关论文
共 50 条
  • [41] Acute graft-versus-host disease
    不详
    NATURE REVIEWS DISEASE PRIMERS, 2023, 9 (01) : 28
  • [42] Pulmonary graft-versus-host disease
    Gadaleta, G
    Angelucci, E
    HAEMATOLOGICA, 2001, 86 (12) : 1322 - 1322
  • [43] Chronic graft-versus-host disease
    Cutler, C
    Antin, JH
    CURRENT OPINION IN ONCOLOGY, 2006, 18 (02) : 126 - 131
  • [44] Graft-versus-host disease management
    Mistrik, M.
    Bojtarova, E.
    Sopko, L.
    Masakova, L.
    Roziakova, L.
    Martinka, J.
    Batorova, A.
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2016, 117 (07): : 388 - 396
  • [45] THE LIVER IN GRAFT-VERSUS-HOST DISEASE
    HIGHTOWER, JA
    EARNEST, DE
    MARTENS, ACM
    ZURCHER, C
    BROUWER, A
    BLAUW, B
    DELEEUW, AM
    HAGENBEEK, A
    ANATOMICAL RECORD, 1986, 214 (03): : A54 - A54
  • [46] GRAFT-VERSUS-HOST DISEASE OF THE INTESTINE
    COX, GJ
    MCDONALD, GB
    SPRINGER SEMINARS IN IMMUNOPATHOLOGY, 1990, 12 (2-3): : 283 - 299
  • [47] GRAFT-VERSUS-HOST REACTIONS AND DISEASE
    SANTOS, GW
    HESS, AD
    VOGELSANG, GB
    IMMUNOLOGICAL REVIEWS, 1985, 88 : 169 - 192
  • [48] Infliximab in graft-versus-host disease
    Rivkina, AM
    Stump, LS
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2002, 59 (13) : 1271 - 1275
  • [49] THALIDOMIDE FOR GRAFT-VERSUS-HOST DISEASE
    MCCARTHY, DM
    KANFER, E
    TAYLOR, J
    BARRETT, AJ
    LANCET, 1988, 2 (8620): : 1135 - 1135
  • [50] Chronic graft-versus-host disease
    Margolis, J
    Vogelsang, G
    JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH, 2000, 9 (03): : 339 - 346